Home » Stocks » MEDP

Medpace Holdings, Inc. (MEDP)

Stock Price: $126.22 USD -0.22 (-0.17%)
Updated November 23, 2:52 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 4.51B
Revenue (ttm) 896.13M
Net Income (ttm) 124.33M
Shares Out 35.77M
EPS (ttm) 3.29
PE Ratio 38.36
Forward PE 29.67
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $126.22
Previous Close $126.43
Change ($) -0.22
Change (%) -0.17%
Day's Open 126.29
Day's Range 124.75 - 127.58
Day's Volume 128,065
52-Week Range 58.72 - 144.49

More Stats

Market Cap 4.51B
Enterprise Value 4.41B
Earnings Date (est) Mar 1, 2021
Ex-Dividend Date n/a
Shares Outstanding 35.77M
Float 27.48M
EPS (basic) 3.46
EPS (diluted) 3.29
FCF / Share 5.09
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.61%
FCF Yield 4.00%
Payout Ratio n/a
Shares Short 815,345
Short Ratio 3.09
Short % of Float 2.97%
Beta 1.36
PE Ratio 38.36
Forward PE 29.67
P/FCF Ratio 24.97
PS Ratio 5.04
PB Ratio 5.71
Revenue 896.13M
Operating Income 148.17M
Net Income 124.33M
Free Cash Flow 180.80M
Net Cash 108.56M
Net Cash / Share 3.03
Gross Margin 60.25%
Operating Margin 16.53%
Profit Margin 13.90%
FCF Margin 20.18%
ROA 7.82%
ROE 16.76%
ROIC 246.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (7)

Buy 3
Overweight 0
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$128.40*
(1.73% upside)
Low
120
Current: $126.22
High
135
Target: 128.40
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue861705436422359
Revenue Growth22.19%61.55%3.46%17.41%-
Gross Profit246216175172156
Operating Income12710164.8652.4920.56
Net Income10073.1939.1213.43-8.67
Shares Outstanding35.8835.5539.0635.6931.35
Earnings Per Share2.671.970.980.37-0.28
EPS Growth35.53%101.02%164.86%--
Operating Cash Flow20215797.3991.7385.87
Capital Expenditures-17.91-16.02-11.72-13.54-6.47
Free Cash Flow18414185.6678.2079.41
Cash & Equivalents13223.2826.4937.4117.74
Total Debt45.2179.72222164378
Net Cash / Debt86.71-56.44-195-126-360
Assets1,143968951979984
Liabilities417378447368571
Book Value726590504611413
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Medpace Holdings, Inc.
Country United States
Employees 3,400
CEO August James Troendle

Stock Information

Ticker Symbol MEDP
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: MEDP
IPO Date August 11, 2016

Description

Medpace Holdings, a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.